ZAMAGNI, CLAUDIO
 Distribuzione geografica
Continente #
AS - Asia 2.570
NA - Nord America 2.240
EU - Europa 1.510
AF - Africa 167
Continente sconosciuto - Info sul continente non disponibili 130
SA - Sud America 101
OC - Oceania 4
Totale 6.722
Nazione #
US - Stati Uniti d'America 2.184
VN - Vietnam 733
CN - Cina 626
SG - Singapore 626
IT - Italia 593
GB - Regno Unito 169
SE - Svezia 156
HK - Hong Kong 151
DE - Germania 132
KR - Corea 106
IN - India 93
NL - Olanda 90
BR - Brasile 69
FR - Francia 67
BD - Bangladesh 65
CI - Costa d'Avorio 63
RU - Federazione Russa 57
IE - Irlanda 45
FI - Finlandia 41
CA - Canada 33
JP - Giappone 33
BG - Bulgaria 31
TG - Togo 26
PH - Filippine 24
SC - Seychelles 24
UA - Ucraina 24
CH - Svizzera 22
JO - Giordania 21
ZA - Sudafrica 20
AT - Austria 18
ID - Indonesia 18
AR - Argentina 17
PL - Polonia 15
BE - Belgio 14
EE - Estonia 9
TH - Thailandia 9
UZ - Uzbekistan 9
EG - Egitto 8
ES - Italia 8
TR - Turchia 8
TW - Taiwan 8
EC - Ecuador 6
IQ - Iraq 6
MX - Messico 6
CZ - Repubblica Ceca 5
NG - Nigeria 5
OM - Oman 5
AE - Emirati Arabi Uniti 4
AU - Australia 4
CR - Costa Rica 4
DZ - Algeria 4
JM - Giamaica 4
MY - Malesia 4
NP - Nepal 4
IR - Iran 3
KE - Kenya 3
NO - Norvegia 3
PK - Pakistan 3
SA - Arabia Saudita 3
SK - Slovacchia (Repubblica Slovacca) 3
TN - Tunisia 3
VE - Venezuela 3
AZ - Azerbaigian 2
CO - Colombia 2
ET - Etiopia 2
HN - Honduras 2
IL - Israele 2
LT - Lituania 2
NI - Nicaragua 2
SN - Senegal 2
TT - Trinidad e Tobago 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
CG - Congo 1
CL - Cile 1
EU - Europa 1
GE - Georgia 1
GH - Ghana 1
GM - Gambi 1
GN - Guinea 1
HR - Croazia 1
KH - Cambogia 1
LB - Libano 1
LC - Santa Lucia 1
MA - Marocco 1
MD - Moldavia 1
ML - Mali 1
NA - Namibia 1
PA - Panama 1
PE - Perù 1
PT - Portogallo 1
PY - Paraguay 1
RO - Romania 1
RS - Serbia 1
SY - Repubblica araba siriana 1
UY - Uruguay 1
Totale 6.594
Città #
Singapore 454
Ashburn 308
Hefei 206
Ho Chi Minh City 177
Hanoi 152
San Jose 148
Bologna 143
Fairfield 142
Hong Kong 140
Chandler 133
Southend 130
Seoul 99
Santa Clara 77
New York 70
Houston 68
Beijing 67
Wilmington 66
Council Bluffs 65
Abidjan 63
Woodbridge 61
Seattle 60
Dallas 54
Los Angeles 53
Ann Arbor 47
Cambridge 46
Boardman 45
Dublin 45
Princeton 42
Haiphong 36
Helsinki 36
Milan 34
Tokyo 29
Da Nang 28
Sofia 28
Lauterbourg 27
Lomé 26
Frankfurt am Main 24
Hyderabad 24
Dong Ket 23
Amman 21
Florence 21
Bengaluru 19
Rimini 19
Nanjing 18
Turin 18
Berlin 16
Bern 16
Chicago 16
Shanghai 16
Vienna 15
Westminster 15
Amsterdam 14
Atlanta 14
Buffalo 13
Jakarta 13
Redondo Beach 13
Rome 13
Saint Petersburg 13
Guangzhou 12
Padova 12
São Paulo 12
Brussels 11
Hải Dương 11
Jacksonville 11
Toronto 11
Warsaw 11
Jinan 10
Redmond 10
Casalecchio di Reno 9
Cesena 9
Falkenstein 9
Falls Church 9
Munich 9
Tongling 9
Brooklyn 8
London 8
Ninh Bình 8
Nuremberg 8
Orem 8
Phoenix 8
Boydton 7
Charlotte 7
Johannesburg 7
Lugo 7
Tashkent 7
Tân Tiến 7
Biên Hòa 6
Bắc Ninh 6
Changsha 6
Des Moines 6
Forlì 6
Hebei 6
Montreal 6
Nanchang 6
Nha Trang 6
San Diego 6
Shenyang 6
Verona 6
Abeokuta 5
Bangkok 5
Totale 4.116
Nome #
Prognostic Impact of Pathologic Features in Molecular Subgroups of Endometrial Carcinoma 318
Mitochondrial DNA genotyping efficiently reveals clonality of synchronous endometrial and ovarian cancers 305
Allogenic sternal transplant after sternectomy for metastasis of ovarian carcinoma. 302
A Single-Centre Experience on the Management of Adenosarcoma: A Successful Report of an Integrated Medical and Surgical Approach 278
Management of malignant cutaneous wounds in oncologic patients 263
Integrated clinicopathologic and molecular analysis of endometrial carcinoma: Prognostic impact of the new ESGO-ESTRO-ESP endometrial cancer risk classification and proposal of histopathologic algorithm for its implementation in clinical practice 253
COVID-19 free oncologic surgical hub: The experience of reallocation of a gynecologic oncology unit during pandemic outbreak 248
Arid1a and ctnnb1/β-catenin molecular status affects the clinicopathologic features and prognosis of endometrial carcinoma: Implications for an improved surrogate molecular classification 248
A regional population-based hereditary breast cancer screening tool in Italy: First 5-year results 244
Trastuzumab resumption after extremely severe cardiotoxicity in metastatic breast cancer patient: A case report 228
Mitochondrial DNA Mutation in Serous Ovarian Cancer: Implications for Mitochondria-Coded Genes in Chemoresistance 214
Liquid biopsy in the diagnosis of HPV DNA in breast lesions 213
Repolarization effects of multiple-cycle chemotherapy and predictors of QTc prolongation: A prospective female cohort study on >2000 ECGs 203
Relevance of ARID1A Mutations in Endometrial Carcinomas 200
Classical Prognostic Factors Predict Prognosis Better than Inflammatory Indices in Locally Advanced Cervical Cancer: Results of a Comprehensive Observational Study including Tumor-, Patient-, and Treatment-Related Data (ESTHER Study) 181
Combination of Electrochemotherapy with Radiotherapy: A Comprehensive, Systematic, PRISMA-Compliant Review of Efficacy and Potential Radiosensitizing Effects in Tumor Control 178
HLA-J, a Non-Pseudogene as a New Prognostic Marker for Therapy Response and Survival in Breast Cancer 178
FDG-PET/CT in advanced ovarian cancer staging: value and pitfalls in detecting lesions in different abdominal and pelvic quadrants compared with laparoscopy. 175
[18F]FDG-PET/CT monitoring early identifies advanced ovarian cancer patients who will benefit from prolonged neo-adjuvant chemotherapy. 174
Optimal number of neoadjuvant chemotherapy cycles prior to interval debulking surgery in advanced epithelial ovarian cancer: a systematic review and meta-analysis of progression-free survival and overall survival 173
Liquid Biopsy in the Management of Breast Cancer Patients: Where Are We Now and Where Are We Going 169
A simple immunohistochemical bio-profile incorporating Bcl2 curbs those cases of invasive breast carcinoma for which an Oncotype Dx characterization is needed 169
Post-operative residual disease and number of cycles of neoadjuvant chemotherapy in advanced epithelial ovarian carcinoma 160
The Neoadjuvant Net: a patient- and surgeon-friendly device to facilitate safe breast-conserving surgery in patients who underwent neoadjuvant treatment 158
Characterization of BRCA Deficiency in Ovarian Cancer 151
null 150
Hyperthermic Intraperitoneal Chemotherapy in Ephitelial Ovarian Cancer should be proposed in eight time points. 134
Exploring pain management in breast cancer: key findings from the ARISE study 132
Radiotherapy in uterine sarcoma: a narrative review of international guidelines 131
Endometrial carcinoma and immune escape: prognostic relevance of HLA class I loss in NSMP subtype 127
Validation of the AJCC prognostic stage for HER2-positive breast cancer in the ShortHER trial 121
Emerging Toxicities of Antibody-Drug Conjugates for Breast Cancer: Clinical Prioritization of Adverse Events from the FDA Adverse Event Reporting System 120
Factors predicting BRCA1/2 pathogenic variants in patients with ovarian cancer: a systematic review with meta-analysis 111
ESR1 analysis of liquid biopsy in breast cancer, one-year routine experience of an Italian clinical referral center 92
High-grade serous carcinoma: a comprehensive genetic and clinico-pathologic study of a heterogeneous neoplasm. 86
Integrated Molecular and Clinicopathologic Study of Tubo-Ovarian High-Grade Serous Carcinoma 86
Safety and efficacy analysis of neoadjuvant pertuzumab, trastuzumab and standard chemotherapy for HER2–positive early breast cancer: real–world data from NeoPowER study 49
Totale 6.722
Categoria #
all - tutte 17.486
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.486


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022452 0 23 31 54 43 18 11 30 22 60 99 61
2022/2023579 54 93 30 52 37 41 17 27 112 15 44 57
2023/2024299 31 28 15 14 16 77 11 46 11 12 16 22
2024/20251.135 104 86 112 63 102 56 98 74 28 104 108 200
2025/20263.049 254 396 226 235 252 120 421 91 548 209 160 137
2026/2027232 152 80 0 0 0 0 0 0 0 0 0 0
Totale 6.722